182 related articles for article (PubMed ID: 38030655)
1. Non-canonical pathway for Rb inactivation and external signaling coordinate cell-cycle entry without CDK4/6 activity.
Zhang M; Kim S; Yang HW
Nat Commun; 2023 Nov; 14(1):7847. PubMed ID: 38030655
[TBL] [Abstract][Full Text] [Related]
2. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
[TBL] [Abstract][Full Text] [Related]
3. Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer.
Kim S; Armand J; Safonov A; Zhang M; Soni RK; Schwartz G; McGuinness JE; Hibshoosh H; Razavi P; Kim M; Chandarlapaty S; Yang HW
Cell Rep; 2023 Nov; 42(11):113198. PubMed ID: 37865915
[TBL] [Abstract][Full Text] [Related]
4. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.
Rivadeneira DB; Mayhew CN; Thangavel C; Sotillo E; Reed CA; Graña X; Knudsen ES
Gastroenterology; 2010 May; 138(5):1920-30. PubMed ID: 20100483
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB.
Schade AE; Oser MG; Nicholson HE; DeCaprio JA
Oncogene; 2019 Jun; 38(25):4962-4976. PubMed ID: 30833638
[TBL] [Abstract][Full Text] [Related]
6. A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition.
Kaulich M; Link VM; Lapek JD; Lee YJ; Glass CK; Gonzalez DJ; Dowdy SF
Sci Rep; 2021 Jul; 11(1):14736. PubMed ID: 34282211
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
[TBL] [Abstract][Full Text] [Related]
8. Cyclin Y binds and activates CDK4 to promote the G1/S phase transition in hepatocellular carcinoma cells via Rb signaling.
Chen L; Wang X; Cheng H; Zhang W; Liu Y; Zeng W; Yu L; Huang C; Liu G
Biochem Biophys Res Commun; 2020 Dec; 533(4):1162-1169. PubMed ID: 33039146
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the Rb--Raf-1 interaction inhibits tumor growth and angiogenesis.
Dasgupta P; Sun J; Wang S; Fusaro G; Betts V; Padmanabhan J; Sebti SM; Chellappan SP
Mol Cell Biol; 2004 Nov; 24(21):9527-41. PubMed ID: 15485920
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic and mitogenic stimuli inactivate Rb by differential utilization of p38 and cyclin-dependent kinases.
Nath N; Wang S; Betts V; Knudsen E; Chellappan S
Oncogene; 2003 Sep; 22(38):5986-94. PubMed ID: 12955077
[TBL] [Abstract][Full Text] [Related]
11. B cell antigen receptor-mediated activation of cyclin-dependent retinoblastoma protein kinases and inhibition by co-cross-linking with Fc gamma receptors.
Tanguay D; Pavlovic S; Piatelli MJ; Bartek J; Chiles TC
J Immunol; 1999 Sep; 163(6):3160-8. PubMed ID: 10477583
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases.
Wang S; Nath N; Minden A; Chellappan S
EMBO J; 1999 Mar; 18(6):1559-70. PubMed ID: 10075927
[TBL] [Abstract][Full Text] [Related]
13. lin-35 Rb and cki-1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans.
Boxem M; van den Heuvel S
Development; 2001 Nov; 128(21):4349-59. PubMed ID: 11684669
[TBL] [Abstract][Full Text] [Related]
14. Rb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinase.
Paternot S; Bockstaele L; Bisteau X; Kooken H; Coulonval K; Roger PP
Cell Cycle; 2010 Feb; 9(4):689-99. PubMed ID: 20107323
[TBL] [Abstract][Full Text] [Related]
15. Melanoma cell autonomous growth: the Rb/E2F pathway.
Halaban R
Cancer Metastasis Rev; 1999; 18(3):333-43. PubMed ID: 10721488
[TBL] [Abstract][Full Text] [Related]
16. Bisphenol S promotes the cell cycle progression and cell proliferation through ERα-cyclin D-CDK4/6-pRb pathway in MCF-7 breast cancer cells.
Lin Z; Zhang X; Zhao F; Ru S
Toxicol Appl Pharmacol; 2019 Mar; 366():75-82. PubMed ID: 30684532
[TBL] [Abstract][Full Text] [Related]
17. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest.
Strobeck MW; Fribourg AF; Puga A; Knudsen ES
Oncogene; 2000 Apr; 19(15):1857-67. PubMed ID: 10773875
[TBL] [Abstract][Full Text] [Related]
18. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
[TBL] [Abstract][Full Text] [Related]
19. Transient Hysteresis in CDK4/6 Activity Underlies Passage of the Restriction Point in G1.
Chung M; Liu C; Yang HW; Köberlin MS; Cappell SD; Meyer T
Mol Cell; 2019 Nov; 76(4):562-573.e4. PubMed ID: 31543423
[TBL] [Abstract][Full Text] [Related]
20. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
Fribourg AF; Knudsen KE; Strobeck MW; Lindhorst CM; Knudsen ES
Cell Growth Differ; 2000 Jul; 11(7):361-72. PubMed ID: 10939590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]